Fibrinogen Early In Severe Trauma StudY II

PHASE3RecruitingINTERVENTIONAL
Enrollment

850

Participants

Timeline

Start Date

November 21, 2022

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions
TraumaHaemorrhagic ShockCoagulopathy
Interventions
DRUG

Fibrinogen Concentrate

3g Fibrinogen Concentrate

OTHER

Cryoprecipitate

10U WB or 4U Apheresis Cryoprecipitate

Trial Locations (2)

4215

RECRUITING

Gold Coast University Hospital, Gold Coast

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

All Listed Sponsors
collaborator

Blood Synergy Program

UNKNOWN

collaborator

Australian and New Zealand Intensive Care Society Clinical Trials Group

NETWORK

collaborator

Australasian College for Emergency Medicine

OTHER

collaborator

Australian Red Cross Lifeblood

UNKNOWN

collaborator

Australasian Trauma Society

UNKNOWN

lead

Australian and New Zealand Intensive Care Research Centre

OTHER